|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2003-12-3
|
|
pubmed:abstractText |
Fifty percent of lung cancers arise in patients over 65 years old and 30% in those over 70. The aim of this study was to evaluate response, survival and tolerability of the combination carboplatin-gemcitabine in elderly patients with advanced non-small cell lung cancer (NSCLC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0169-5002
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
345-54
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:14644523-Aged,
pubmed-meshheading:14644523-Aged, 80 and over,
pubmed-meshheading:14644523-Antimetabolites, Antineoplastic,
pubmed-meshheading:14644523-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:14644523-Carboplatin,
pubmed-meshheading:14644523-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:14644523-Deoxycytidine,
pubmed-meshheading:14644523-Dose-Response Relationship, Drug,
pubmed-meshheading:14644523-Female,
pubmed-meshheading:14644523-Humans,
pubmed-meshheading:14644523-Lung Neoplasms,
pubmed-meshheading:14644523-Male,
pubmed-meshheading:14644523-Middle Aged,
pubmed-meshheading:14644523-Multivariate Analysis,
pubmed-meshheading:14644523-Neoplasm Staging,
pubmed-meshheading:14644523-Survival Analysis,
pubmed-meshheading:14644523-Survival Rate,
pubmed-meshheading:14644523-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer.
|
|
pubmed:affiliation |
Department of Oncology, Hospital Virgen de Los Lirios, Poli;gono de Caramanxel s/n, 03804 Alcoy, Spain. mm@falcon-es.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
